Serum hepatocyte growth factor levels in patients with Epstein-Barr virus–positive and Epstein-Barr virus–negative Hodgkin disease
. | EBV+ HD . | EBV− HD . |
---|---|---|
Patients, no. | 14 | 14 |
Serum HGF levels, pg/mL | ||
Median | 1231 | 1035 |
Range | 338-2874 | 352-2275 |
Mean ± SEM | 1134 ± 222 | 1164 ± 146 |
95% CI | 854-1813 | 846-1481 |
P3-150 | .73 |
. | EBV+ HD . | EBV− HD . |
---|---|---|
Patients, no. | 14 | 14 |
Serum HGF levels, pg/mL | ||
Median | 1231 | 1035 |
Range | 338-2874 | 352-2275 |
Mean ± SEM | 1134 ± 222 | 1164 ± 146 |
95% CI | 854-1813 | 846-1481 |
P3-150 | .73 |
There were no differences found in HGF levels of patients with HD at diagnosis, according to the presence or lack of EBV infection.
EBV indicates Epstein-Barr virus; HD, Hodgkin disease; HGF, hepatocyte growth factor; CI, confidence interval.
P value is based on the Mann-Whitney test.